133 related articles for article (PubMed ID: 29422244)
21. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone reverses the effects of high glucose on human retinal endothelial cell permeability and proliferation in vitro.
Stewart EA; Saker S; Amoaku WM
Exp Eye Res; 2016 Oct; 151():75-81. PubMed ID: 27523466
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
25. Nicotine promotes blood retinal barrier damage in a model of human diabetic macular edema.
Maugeri G; D'Amico AG; Rasà DM; La Cognata V; Saccone S; Federico C; Cavallaro S; D'Agata V
Toxicol In Vitro; 2017 Oct; 44():182-189. PubMed ID: 28689815
[TBL] [Abstract][Full Text] [Related]
26. KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF.
Chen X; Li J; Li M; Zeng M; Li T; Xiao W; Li J; Wu Q; Ke X; Luo D; Tang S; Luo Y
Diabetes Obes Metab; 2013 Mar; 15(3):224-33. PubMed ID: 22958404
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of hemopexin in the diabetic eye: a new pathogenic candidate for diabetic macular edema.
Hernández C; Garcia-Ramírez M; Simó R
Diabetes Care; 2013 Sep; 36(9):2815-21. PubMed ID: 23620477
[TBL] [Abstract][Full Text] [Related]
28. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
29. Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells.
Deissler HL; Lang GK; Lang GE
Exp Eye Res; 2014 May; 122():20-31. PubMed ID: 24631334
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy.
Wang L; Wang N; Tan HY; Zhang Y; Feng Y
J Ethnopharmacol; 2015 Jul; 169():295-304. PubMed ID: 25929449
[TBL] [Abstract][Full Text] [Related]
31. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin D: an Mϕ-derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy.
Monickaraj F; McGuire PG; Nitta CF; Ghosh K; Das A
FASEB J; 2016 Apr; 30(4):1670-82. PubMed ID: 26718887
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor ligand-related molecule 1A maintains blood-retinal barrier via modulating SHP-1-Src-VE-cadherin signaling in diabetic retinopathy.
Li J; Xie R; Jiang F; Li Y; Zhu Y; Liu Z; Liao M; Liu Y; Meng X; Chen S; Yu J; Du M; Wang X; Chen Y; Yan H
FASEB J; 2021 Nov; 35(11):e22008. PubMed ID: 34679191
[TBL] [Abstract][Full Text] [Related]
34. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
35. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone.
Brooks HL; Caballero S; Newell CK; Steinmetz RL; Watson D; Segal MS; Harrison JK; Scott EW; Grant MB
Arch Ophthalmol; 2004 Dec; 122(12):1801-7. PubMed ID: 15596583
[TBL] [Abstract][Full Text] [Related]
36. Fenofibrate prevents the disruption of the outer blood retinal barrier through downregulation of NF-κB activity.
Garcia-Ramírez M; Hernández C; Palomer X; Vázquez-Carrera M; Simó R
Acta Diabetol; 2016 Feb; 53(1):109-18. PubMed ID: 25936740
[TBL] [Abstract][Full Text] [Related]
37. TRPV4 inhibition prevents increased water diffusion and blood-retina barrier breakdown in the retina of streptozotocin-induced diabetic mice.
Orduña Ríos M; Noguez Imm R; Hernández Godínez NM; Bautista Cortes AM; López Escalante DD; Liedtke W; Martínez Torres A; Concha L; Thébault S
PLoS One; 2019; 14(5):e0212158. PubMed ID: 31048895
[TBL] [Abstract][Full Text] [Related]
38. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
